Eli Lilly CEO David Ricks was named the Indianapolis Business Journal's 'Newsmaker of the Year' for the fourth consecutive time. The recognition highlights the company's achievements throughout 2025.
The company's market capitalization flirted with the $1 trillion mark during the year. This surge was primarily driven by the blockbuster success of the weight-loss drug Zepbound. Investor optimism for the pipeline also propelled the stock price past $1,000 per share.
Key developments included securing fast-track FDA review for the anticipated oral weight-loss pill, orforglipron. Lilly also secured an agreement with the White House to enhance Medicare coverage for its obesity drugs. The feature underscores significant investor confidence in Lilly's strategic direction and drug portfolio.